Impact of Body Mass Index on Survival Outcomes of Patients with Metastatic Renal Cell Carcinoma in the Immuno-oncology Era: A Systematic Review and Meta-analysis

Kosuke null Takemura, Satoru Yonekura, Laura Emily Downey, Dimitris Evangelopoulos, Daniel Y.C. Heng
ISSN / E-ISSN
— / —
DOI
10.1016/j.euros.2022.03.002 ↗
Volume · Issue · Pages
39 · — · 62-71
Publisher
Elsevier BV
Article URL
https://doi.org/10.1016/j.euros.2022.03.002 ↗
Article details
Unverified
Publication date (each date has its type and source)
04 Apr 2022
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date04 Apr 2022 OpenAlex

Keywords (as given): body mass index; metastatic renal cell carcinoma; obesity paradox; immune checkpoint inhibitors; immunotherapy; overall survival; progression-free survival; prognostic factors; overweight

HEC Status at Publication Not the journal's current status

HEC Status at PublicationConclusive
HEC status at publication Recognized Y
Based on the recorded HEC dataset applicable to the article's publication date. Listed as Y in the HEC list for hjrs 2021-22 V2.
Journal
European Urology Open Science
Publication date used
04 Apr 2022 (OpenAlex publication date)
Applicable HEC period
hjrs 2021-22 V2 (version 1) · 01 Jul 2021 – 30 Jun 2022
Category
Y
Recognition status
Recognized (OK_RECORD_FOUND)
Source
hjrs-2021-22 row 19776
Verification status
Verified against source · last verified 16 Oct 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.